Relative benefits of newer adjuvant chemotherapy regimens in luminal breast cancer subtypes
- PMID: 27020949
- DOI: 10.1016/j.breast.2016.02.011
Relative benefits of newer adjuvant chemotherapy regimens in luminal breast cancer subtypes
Comment on
-
Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancer.Breast. 2016 Jun;27:187-8. doi: 10.1016/j.breast.2016.02.002. Epub 2016 Apr 23. Breast. 2016. PMID: 27118634 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources